Improved linker-payload for antibody binding, pharmaceutical composition and its applications

JP2026520334APending Publication Date: 2026-06-23OBI PHARMA INC

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
OBI PHARMA INC
Filing Date
2024-09-20
Publication Date
2026-06-23

Smart Images

  • Figure 2026520334000001_ABST
    Figure 2026520334000001_ABST
Patent Text Reader

Abstract

The present invention provides a linker-payload complex containing a bioorthogonal group and a hydrophilic moiety. The improved linker-payload and improved antibody-drug conjugate (ADC) for antibody complexation exhibit greater stability in blood circulation and improve drug delivery and release efficiency in target cells. The present invention also relates to pharmaceutical compositions comprising antibodies against several antigen targets (e.g., TROP2, HER2, Nectin-4, etc.), their antigen-binding fragments, and ADCs. Furthermore, methods for using ADCs for the treatment of subjects with pathological conditions are also provided.
Need to check novelty before this filing date? Find Prior Art